Role of invasive electrophysiologic studies in the evaluation and treatment of supraventricular tachycardia.
Electrophysiologic studies have provided new insights into the mechanisms responsible for supraventricular arrhythmias and have enabled investigators to evaluate with precision the acute effects of pharmacologic, physiologic, electrical, and surgical interventions. Not all patients with supraventricular arrhythmias require invasive studies, however, since empiric drug trials will often be adequate for management. At present, the clinical indications for study include the following: (1) for diagnosis of tachycardia mechanism when scalar ECG analysis is uncertain; (2) for assessment of risk of future life-threatening arrhythmia; and (3) as a rapid means of assessing future therapy when sporadic arrhythmias are likely to be poorly tolerated. Innovations that include surgical and catheter ablations of tachycardia pathways and antitachycardia pacing devices hold great promise and in the future, will provide nonpharmacologic options for patients poorly controlled by or intolerant of drug therapy.